Association of polygenic risk scores and family history with the risk of chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Kleinstern, Geffen
de Sanjose, Silvia
Camp, Nicola
Vajdic, Claire M.
Call, Timothy G.
Liebow, Mark
Robinson, Dennis
Kay, Neil E.
Cunningham, Julie
Benavente, Yolanda
Monnereau, Alain
Spinelli, John
Cerhan, James R.
Slager, Susan L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4267
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease
    Park, Mincheol
    Lee, Young-gun
    NEUROLOGY-GENETICS, 2024, 10 (01)
  • [32] Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes
    Kleinstern, Geffen
    Weinberg, J. Brice
    Parikh, Sameer A.
    Braggio, Esteban
    Robinson, Dennis P.
    Norman, Aaron D.
    Rabe, Kari G.
    Vachon, Celine M.
    Lesnick, Connie E.
    Call, Timothy G.
    Brander, Danielle M.
    Olson, Janet E.
    Cerhan, James R.
    Kay, Neil E.
    Hanson, Curtis A.
    Furman, Richard R.
    Shanafelt, Tait
    Slager, Susan L.
    BLOOD, 2020, 136
  • [33] Role of polygenic risk scores in the association between chronotype and health risk behaviors
    Zhang, Yi
    Li, Shuqin
    Xie, Yang
    Xiao, Wan
    Xu, Huiqiong
    Jin, Zhengge
    Li, Ruoyu
    Wan, Yuhui
    Tao, Fangbiao
    BMC PSYCHIATRY, 2023, 23 (01)
  • [34] Role of polygenic risk scores in the association between chronotype and health risk behaviors
    Yi Zhang
    Shuqin Li
    Yang Xie
    Wan Xiao
    Huiqiong Xu
    Zhengge Jin
    Ruoyu Li
    Yuhui Wan
    Fangbiao Tao
    BMC Psychiatry, 23
  • [35] PSEUDOHYPERKALEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Abdulrahman, Rula
    Saxena, Ramesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 643 - 643
  • [36] Chronic lymphocytic leukemia (CLL)Then and now
    Rai, Kanti R.
    Jain, Preetesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : 330 - 341
  • [37] PROGNOSIS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    PHILLIPS, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 274 - 274
  • [38] The treatment of complicated and high risk chronic lymphocytic leukemia (CLL) with fludarabine, cyclophosphamide and rituximab (FCR).
    Donthireddy, V
    Shurafa, MS
    Saleh, M
    Kamboj, G
    Wang, D
    Janakiraman, N
    BLOOD, 2005, 106 (11) : 341B - 341B
  • [39] Chronic lymphocytic Leukemia (CLL) Ibrutinib in the First Line: Standard for High-risk Patients
    Pickl, Susanne
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (1-2) : 76 - 76
  • [40] Polymorphisms in apoptotis and immunoregulatory related genes are associated with an increased risk of chronic lymphocytic leukemia (CLL)
    Enjuanes, A.
    Benavente, Y.
    Bosch, F.
    Colomer, D.
    Perez-Alvarez, S.
    Martin-Guerrero, I.
    Reina, O.
    Ardanaz, M.
    Jares, P.
    Garcia-Orad, A.
    Pujana, M. A.
    Montserrat, E.
    De Sanjose, S.
    Campo, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 89 - 89
12345